[{"Assets_0_Q1_USD":12115059000.0,"CIK":"875320","CommonStockSharesConverted_0_Q1_shares":258829000.0,"CommonStockSharesOutstanding_0_Q1_shares":258829000.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":2.52,"EarningsPerShareDiluted_1_Q1_USD":2.49,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":921055000.0,"NetIncomeLossConverted_1_Q1_USD":653138000.0,"OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q1_USD":1724305000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q1_USD":8980254000.0,"Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":261916000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":259369000.0,"filed":"20210430","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2021.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20210331","qtrs":"1","uom":"USD"}]